<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02448043</url>
  </required_header>
  <id_info>
    <org_study_id>STU00200526</org_study_id>
    <nct_id>NCT02448043</nct_id>
  </id_info>
  <brief_title>Cutaneous Prostaglandin Application: Nail Growth, Nail Brittleness, and Eye Pressure</brief_title>
  <official_title>Cutaneous Prostaglandin Application: Nail Growth, Nail Brittleness, and Eye Pressure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Allergan</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Topical prostaglandin agents are used to help reduce eye pressure in glaucoma patients.
      Bimatoprost (Lumigan 0.01%) is such an agent (Allergan, Inc.). Several of our patients on
      bimatoprost and an observational study of patients on bimatoprost in another center reported
      that fingernails grew longer and became less brittle using the topical eye drops to the eyes.
      The purpose of the double-blinded study is to determine whether the application of the eye
      drops directly to the proximal nail fold of one hand using the opposite hand as a control
      will result in longer nails, less brittle nails, and reduced eye pressures should any of the
      medication be absorbed into the systemic circulation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In addition to our observations with topical bimatoprost on fingernail growth, Wand and
      colleagues applied bimatoprost to the base of the fingernails demonstrating a 16.9% increase
      in fingernail growth from baseline, and a 10.4% increase from baseline on untreated nail
      beds. Other than these two reports, there are no studies addressing this topic to our
      knowledge based on a Medline search for off-label use of this drug. Other relevant studies
      have addressed increased hair and eyelash growth with the prostaglandin agents. Researching
      the biochemistry of the relationship of prostaglandins to hair and nail growth, the final
      common pathway appears to be with protein kinase C and the production of tropocollagens. The
      dermatology literature has demonstrated that both hair and nail keratocytes reside in the
      nail bed suggesting that increased collagen production may enhance the growth of both the
      nail bed and nail plate, possibly reducing nail brittleness.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 4, 2015</start_date>
  <completion_date type="Actual">May 6, 2016</completion_date>
  <primary_completion_date type="Actual">May 6, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change From Baseline in Nail Length of Hands</measure>
    <time_frame>Baseline, 30 days</time_frame>
    <description>Measured by digital calipers (Ironton 6 in. Stainless Steel Digital Fractional Caliper, Northern Tool and Equipment, Burnsville, MN, USA)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Nail Length of Digits</measure>
    <time_frame>Baseline, 30 Days</time_frame>
    <description>Measured by digital calipers (Ironton 6 in. Stainless Steel Digital Fractional Caliper, Northern Tool and Equipment, Burnsville, MN, USA)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intraocular Pressure at 30 Days of Treatment</measure>
    <time_frame>Between 7:30 AM and 10:00 AM at 30 days post treatment</time_frame>
    <description>IOP using a Goldmann applanation tonometer (GAT) between 7:30 AM and 10:00 AM</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Nail Brittleness at 30 Days of Treatment</measure>
    <time_frame>Baseline, 30 days</time_frame>
    <description>Scale Title: Nail Brittleness (1-4)
Subjective assessment by subjects on scale of 1 (no brittleness) to 4 (maximum brittleness).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Days Until the First Nail Chipped</measure>
    <time_frame>Baseline to 30 days</time_frame>
    <description>Average number of days post-treatment until the first nail chipped</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Skin Pigmentation on Hands</measure>
    <time_frame>Baseline, 30 days</time_frame>
    <description>Photographs taken (knuckle to fingertips over white paper with consistent bulb illumination at the site), with an Apple iPhone 6 (Cupertino, CA, USA) and examined. The investigators reviewed the anonymous photos by number to look for comparative skin pigmentation (increased pigmentation, decreased pigmentation, no change in pigmentation) changes on the hands.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Hirsutism on Hands</measure>
    <time_frame>Baseline, 30 days</time_frame>
    <description>Photographs taken (knuckle to fingertips over white paper with consistent bulb illumination at the site), with an Apple iPhone 6 (Cupertino, CA, USA) and examined. The investigators reviewed the anonymous photos by number to look for comparative (increased hair growth, decreased hair growth, no change) hair changes on the hands.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Nail Growth Cessation</condition>
  <condition>Intraocular Pressure</condition>
  <arm_group>
    <arm_group_label>Right Hand Bimatoprost 0.01% drops, Left Hand Placebo</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Bimatoprost 0.01% drops placed on the proximal nail folds of the right hand digits two times per day for 30 days.
Saline solution drops placed on the proximal nail folds of the left hand digits two times per day for 30 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Left Hand Bimatoprost 0.01% drops, Right Hand Placebo</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Bimatoprost 0.01% drops placed on the proximal nail folds of the left hand digits two times per day for 30 days.
Saline solution drops placed on the proximal nail folds of the right hand digits two times per day for 30 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bimatoprost 0.01%</intervention_name>
    <description>Bimatoprost drops added to the proximal nail folds of the randomized study hand digits two times per day for 30 days</description>
    <arm_group_label>Left Hand Bimatoprost 0.01% drops, Right Hand Placebo</arm_group_label>
    <arm_group_label>Right Hand Bimatoprost 0.01% drops, Left Hand Placebo</arm_group_label>
    <other_name>Lumigan 0.01%</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo: saline</intervention_name>
    <description>Placebo drops added to the proximal nail folds of the hand digits opposite the study hand two times per day for 30 days</description>
    <arm_group_label>Left Hand Bimatoprost 0.01% drops, Right Hand Placebo</arm_group_label>
    <arm_group_label>Right Hand Bimatoprost 0.01% drops, Left Hand Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  English speaking

          -  Normotensive or glaucoma suspects on no ocular medications

          -  No manicure within 2 weeks of the study.

        Exclusion Criteria:

          -  Individuals on topical or systemic essential fatty acids (EFA's) in hand lotions,
             creams, ointments, or medication, or on biotin.

          -  Digits with signs of nail injury, deformity, or infection.

          -  Nail biters, nail polishers, artificial nail wear or gels, and nail and trimming and
             filing until the study endpoint.

          -  Women of childbearing age who are pregnant or who are trying to become pregnant.

          -  Individuals with allergies or sensitivity to prostaglandin agents.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David J Palmer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>David J. Palmer, MD</name>
      <address>
        <city>Glenview</city>
        <state>Illinois</state>
        <zip>60026</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Weston BC. Migraine headache associated with latanoprost. Arch Ophthalmol. 2001 Feb;119(2):300-1.</citation>
    <PMID>11176999</PMID>
  </reference>
  <reference>
    <citation>Ziboh VA, Miller CC. Essential fatty acids and polyunsaturated fatty acids: significance in cutaneous biology. Annu Rev Nutr. 1990;10:433-50. Review.</citation>
    <PMID>2200473</PMID>
  </reference>
  <results_reference>
    <citation>Khouri AS, Fechtner RD, Zimmerman, TJ. Latanoprost: A New Approach to the Treatment of Glaucoma. Today's Therapeutic Trends 14: 225-240, 1997</citation>
  </results_reference>
  <results_reference>
    <citation>Woodward DF, Krauss AH, Chen J, Lai RK, Spada CS, Burk RM, Andrews SW, Shi L, Liang Y, Kedzie KM, Chen R, Gil DW, Kharlamb A, Archeampong A, Ling J, Madhu C, Ni J, Rix P, Usansky J, Usansky H, Weber A, Welty D, Yang W, Tang-Liu DD, Garst ME, Brar B, Wheeler LA, Kaplan LJ. The pharmacology of bimatoprost (Lumigan). Surv Ophthalmol. 2001 May;45 Suppl 4:S337-45. Review. Erratum in: Surv Ophthalmol 2002 May-Jun;47(3):295.</citation>
    <PMID>11434936</PMID>
  </results_reference>
  <results_reference>
    <citation>Bean GW, Camras CB. Commercially available prostaglandin analogs for the reduction of intraocular pressure: similarities and differences. Surv Ophthalmol. 2008 Nov;53 Suppl1:S69-84. doi: 10.1016/j.survophthal.2008.08.012. Review.</citation>
    <PMID>19038626</PMID>
  </results_reference>
  <results_reference>
    <citation>Sjoquist B. Human pharmacokinetic studies summary. Pharmacia and Upjohn Company Technical Report 9500155. March 25, 1995.</citation>
  </results_reference>
  <results_reference>
    <citation>Tan J, Berke S. Latanoprost-induced prostaglandin-associated periorbitopathy. Optom Vis Sci. 2013 Sep;90(9):e245-7; discussion 1029. doi: 10.1097/OPX.0b013e31829d8dd7.</citation>
    <PMID>23912967</PMID>
  </results_reference>
  <results_reference>
    <citation>Wand M, Shields BM. Cystoid macular edema in the era of ocular hypotensive lipids. Am J Ophthalmol. 2002 Mar;133(3):393-7. Review.</citation>
    <PMID>11915838</PMID>
  </results_reference>
  <results_reference>
    <citation>Cohen JL. Enhancing the growth of natural eyelashes: the mechanism of bimatoprost-induced eyelash growth. Dermatol Surg. 2010 Sep;36(9):1361-71. doi: 10.1111/j.1524-4725.2010.01522.x. Review.</citation>
    <PMID>20384750</PMID>
  </results_reference>
  <results_reference>
    <citation>Johnstone MA. Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral topical latanoprost. Am J Ophthalmol. 1997 Oct;124(4):544-7.</citation>
    <PMID>9323945</PMID>
  </results_reference>
  <results_reference>
    <citation>Wand M. New side effect of Prostaglandins. Agsocietynet@aaoforums.aao.org. Jan 2015.</citation>
  </results_reference>
  <results_reference>
    <citation>Seed Oils and Essential Fatty Acids. Retrieved 5/21/12 http://www.naturopathica.com/system/user_files/attachments/7/original/Naturopathica_Seed_Oils.pdf</citation>
  </results_reference>
  <results_reference>
    <citation>Janis J (ed). Nail bed injuries. Essential of Plastic Surgery: A UT Southwestern Medical Center Handbook. St Louis, MO: Quality Medical Publishing, Inc: 560-567, 2007.</citation>
  </results_reference>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>May 4, 2015</study_first_submitted>
  <study_first_submitted_qc>May 18, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 19, 2015</study_first_posted>
  <results_first_submitted>June 9, 2019</results_first_submitted>
  <results_first_submitted_qc>November 26, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">December 13, 2019</results_first_posted>
  <last_update_submitted>November 26, 2019</last_update_submitted>
  <last_update_submitted_qc>November 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwestern University</investigator_affiliation>
    <investigator_full_name>David Palmer</investigator_full_name>
    <investigator_title>Assistant Professor of Clinical Ophthalmology</investigator_title>
  </responsible_party>
  <keyword>brittleness</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bimatoprost</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Subjects were recruited voluntarily from private office practices (DP and AS), and a university‚Äêbased practice (AT).</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Right Hand Bimatoprost 0.01% Drops, Left Hand Placebo</title>
          <description>Bimatoprost 0.01% drops placed on the proximal nail folds of the right hand digits two times per day for 30 days.
Saline solution drops placed on the proximal nail folds of the left hand digits two times per day for 30 days.</description>
        </group>
        <group group_id="P2">
          <title>Left Hand Bimatoprost 0.01% Drops, Right Hand Placebo</title>
          <description>Bimatoprost 0.01% drops placed on the proximal nail folds of the left hand digits two times per day for 30 days.
Saline solution drops placed on the proximal nail folds of the right hand digits two times per day for 30 days.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="22"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="18"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Right Hand Bimatoprost 0.01% Drops, Left Hand Placebo</title>
          <description>Bimatoprost 0.01% drops placed on the proximal nail folds of the right hand digits two times per day for 30 days.
Saline solution drops placed on the proximal nail folds of the left hand digits two times per day for 30 days</description>
        </group>
        <group group_id="B2">
          <title>Left Hand Bimatoprost 0.01% Drops, Right Hand Placebo</title>
          <description>Bimatoprost 0.01% drops placed on the proximal nail folds of the left hand digits two times per day for 30 days.
Saline solution drops placed on the proximal nail folds of the right hand digits two times per day for 30 days.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="18"/>
            <count group_id="B3" value="38"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>Range from 24-88 years of age</description>
          <population>Number analyzed for each row differs from the Overall analyzed number because the 'All Participants', 'Male', and 'Female' rows identify different populations</population>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>All participants</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="18"/>
                    <count group_id="B3" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60.30" spread="9.27"/>
                    <measurement group_id="B2" value="63.33" spread="15.26"/>
                    <measurement group_id="B3" value="61.61" spread="12.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="2"/>
                    <count group_id="B2" value="1"/>
                    <count group_id="B3" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67" spread="7.07"/>
                    <measurement group_id="B2" value="88" spread="0"/>
                    <measurement group_id="B3" value="74" spread="13.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Female</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="18"/>
                    <count group_id="B2" value="17"/>
                    <count group_id="B3" value="35"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="59.28" spread="9.19"/>
                    <measurement group_id="B2" value="61.88" spread="14.39"/>
                    <measurement group_id="B3" value="60.5" spread="11.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="18"/>
                    <count group_id="B3" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="35"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>White</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="18"/>
                    <count group_id="B3" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="18"/>
                    <count group_id="B3" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="18"/>
                    <count group_id="B3" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="18"/>
                    <count group_id="B3" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Nail Length of Hands</title>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="18"/>
                    <count group_id="B3" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12.5" spread="1.32"/>
                    <measurement group_id="B2" value="12.21" spread="1.74"/>
                    <measurement group_id="B3" value="12.39" spread="1.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Nail Length of Digits</title>
          <population>In the &quot;Left Hand Bimatoprost, Right Hand Placebo&quot; group, 1 subject is missing a forefinger</population>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>Thumb</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="18"/>
                    <count group_id="B3" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14.50" spread="1.68"/>
                    <measurement group_id="B2" value="13.85" spread="2.10"/>
                    <measurement group_id="B3" value="14.18" spread="0.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Forefinger</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="17"/>
                    <count group_id="B3" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12.26" spread="1.64"/>
                    <measurement group_id="B2" value="12.28" spread="1.94"/>
                    <measurement group_id="B3" value="12.27" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Middle Finger</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="18"/>
                    <count group_id="B3" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12.81" spread="1.70"/>
                    <measurement group_id="B2" value="12.52" spread="2.08"/>
                    <measurement group_id="B3" value="12.67" spread="0.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ring Finger</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="18"/>
                    <count group_id="B3" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12.50" spread="1.60"/>
                    <measurement group_id="B2" value="12.21" spread="2.04"/>
                    <measurement group_id="B3" value="12.35" spread="0.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pinky Finger</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="18"/>
                    <count group_id="B3" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10.42" spread="1.43"/>
                    <measurement group_id="B2" value="10.26" spread="1.66"/>
                    <measurement group_id="B3" value="10.34" spread="0.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Intraocular Pressure</title>
          <population>No baseline IOP data on 13 subjects</population>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>Both eyes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="13"/>
                    <count group_id="B2" value="12"/>
                    <count group_id="B3" value="25"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16.23" spread="3.85"/>
                    <measurement group_id="B2" value="13.67" spread="2.91"/>
                    <measurement group_id="B3" value="15" spread="3.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Right eye</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="13"/>
                    <count group_id="B2" value="12"/>
                    <count group_id="B3" value="25"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16.00" spread="2.89"/>
                    <measurement group_id="B2" value="13.83" spread="3.24"/>
                    <measurement group_id="B3" value="14.96" spread="3.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Left eye</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="13"/>
                    <count group_id="B2" value="12"/>
                    <count group_id="B3" value="25"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16.46" spread="4.74"/>
                    <measurement group_id="B2" value="13.5" spread="2.68"/>
                    <measurement group_id="B3" value="15.04" spread="4.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Nail Brittleness</title>
          <description>Scale Title: Nail Brittleness (1-4)
Subjective assessment by subjects on scale of 1 (no brittleness) to 4 (maximum brittleness).</description>
          <population>No or incomplete data 2 participants</population>
          <units>Score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="18"/>
                    <count group_id="B2" value="18"/>
                    <count group_id="B3" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.61" spread="0.98"/>
                    <measurement group_id="B2" value="2.42" spread="1.06"/>
                    <measurement group_id="B3" value="2.51" spread="1.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Nail Length of Hands</title>
        <description>Measured by digital calipers (Ironton 6 in. Stainless Steel Digital Fractional Caliper, Northern Tool and Equipment, Burnsville, MN, USA)</description>
        <time_frame>Baseline, 30 days</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>Bimatoprost 0.01% Drops</title>
            <description>Bimatoprost 0.01%: Bimatoprost drops added to the proximal nail folds of the randomized study hand digits two times per day for 30 days</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Saline solution drops placed on the proximal nail folds of the hand digits opposite from the study hand two times per day for 30 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Nail Length of Hands</title>
          <description>Measured by digital calipers (Ironton 6 in. Stainless Steel Digital Fractional Caliper, Northern Tool and Equipment, Burnsville, MN, USA)</description>
          <population>Intent to treat population</population>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Hands</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Hands</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Total Nail Growth (power = 1.0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.49" spread="1.14"/>
                    <measurement group_id="O2" value="15.10" spread="1.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Individual Nail Growth</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.34" spread="0.33"/>
                    <measurement group_id="O2" value="1.51" spread="0.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.532</p_value>
            <p_value_desc>Threshold is p&lt;0.05</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Nail Length of Digits</title>
        <description>Measured by digital calipers (Ironton 6 in. Stainless Steel Digital Fractional Caliper, Northern Tool and Equipment, Burnsville, MN, USA)</description>
        <time_frame>Baseline, 30 Days</time_frame>
        <population>Excluding the negative growth nails and chipped nails combined; one subject is missing a forefinger</population>
        <group_list>
          <group group_id="O1">
            <title>Bimatoprost 0.01% Drops</title>
            <description>Bimatoprost 0.01%: Bimatoprost drops added to the proximal nail folds of the randomized study hand digits two times per day for 30 days</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Saline solution drops placed on the proximal nail folds of the hand digits opposite from the study hand two times per day for 30 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Nail Length of Digits</title>
          <description>Measured by digital calipers (Ironton 6 in. Stainless Steel Digital Fractional Caliper, Northern Tool and Equipment, Burnsville, MN, USA)</description>
          <population>Excluding the negative growth nails and chipped nails combined; one subject is missing a forefinger</population>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Digits</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Digits</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="189"/>
                <count group_id="O2" value="190"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Thumb</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="38"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Digits</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.58" spread="1.70"/>
                    <measurement group_id="O2" value="1.48" spread="1.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Forefinger</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="38"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Digits</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.26" spread="1.38"/>
                    <measurement group_id="O2" value="1.02" spread="2.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Middle Finger</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="38"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Digits</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.90" spread="1.76"/>
                    <measurement group_id="O2" value="1.40" spread="1.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ring Finger</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="38"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Digits</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.33" spread="1.27"/>
                    <measurement group_id="O2" value="1.76" spread="1.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pinky Finger</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="38"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Digits</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.63" spread="1.55"/>
                    <measurement group_id="O2" value="1.62" spread="1.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.523</p_value>
            <p_value_desc>Threshold is p&lt;0.05</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Intraocular Pressure at 30 Days of Treatment</title>
        <description>IOP using a Goldmann applanation tonometer (GAT) between 7:30 AM and 10:00 AM</description>
        <time_frame>Between 7:30 AM and 10:00 AM at 30 days post treatment</time_frame>
        <population>No IOP data on 13 subjects Missing final IOP data on 1 subject
Arms are not grouped as ‚ÄòBimatoprost 0.01%‚Äô and ‚ÄòPlacebo‚Äô because this is a split-person study, so every participant received both the treatment and the placebo. Since this outcome is measuring eye pressure, there is no way to distinguish which group/arm is influencing eye pressure.</population>
        <group_list>
          <group group_id="O1">
            <title>Right Hand Bimatoprost 0.01% Drops, Left Hand Placebo</title>
            <description>Bimatoprost 0.01% drops placed on the proximal nail folds of the right hand digits two times per day for 30 days.
Saline solution drops placed on the proximal nail folds of the left hand digits two times per day for 30 days</description>
          </group>
          <group group_id="O2">
            <title>Left Hand Bimatoprost 0.01% Drops, Right Hand Placebo</title>
            <description>Bimatoprost 0.01% drops placed on the proximal nail folds of the left hand digits two times per day for 30 days.
Saline solution drops placed on the proximal nail folds of the right hand digits two times per day for 30 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Intraocular Pressure at 30 Days of Treatment</title>
          <description>IOP using a Goldmann applanation tonometer (GAT) between 7:30 AM and 10:00 AM</description>
          <population>No IOP data on 13 subjects Missing final IOP data on 1 subject
Arms are not grouped as ‚ÄòBimatoprost 0.01%‚Äô and ‚ÄòPlacebo‚Äô because this is a split-person study, so every participant received both the treatment and the placebo. Since this outcome is measuring eye pressure, there is no way to distinguish which group/arm is influencing eye pressure.</population>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Both eyes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="11"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Eyes</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="26"/>
                    <count group_id="O2" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.42" spread="3.24"/>
                    <measurement group_id="O2" value="13.91" spread="1.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Right eye</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="11"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Eyes</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.38" spread="3.73"/>
                    <measurement group_id="O2" value="14.0" spread="2.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Left eye</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="11"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Eyes</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.46" spread="2.82"/>
                    <measurement group_id="O2" value="13.82" spread="1.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparing baseline values of both arms to completion values of both arms</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.912</p_value>
            <p_value_desc>Threshold is p&lt;0.05</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Nail Brittleness at 30 Days of Treatment</title>
        <description>Scale Title: Nail Brittleness (1-4)
Subjective assessment by subjects on scale of 1 (no brittleness) to 4 (maximum brittleness).</description>
        <time_frame>Baseline, 30 days</time_frame>
        <population>No or incomplete data on seven subjects
Subjects were asked to assess nail brittleness of both hands and rank them together ‚Äì i.e. the value each subject gave for nail brittleness was the combination of the placebo hand and the treatment hand. Nail brittleness values were not distinguished between the placebo hands and the treatment hands.</population>
        <group_list>
          <group group_id="O1">
            <title>Right Hand Bimatoprost 0.01% Drops, Left Hand Placebo</title>
            <description>Bimatoprost 0.01% drops placed on the proximal nail folds of the right hand digits two times per day for 30 days.
Saline solution drops placed on the proximal nail folds of the left hand digits two times per day for 30 days.</description>
          </group>
          <group group_id="O2">
            <title>Left Hand Bimatoprost 0.01% Drops, Right Hand Placebo</title>
            <description>Bimatoprost 0.01% drops placed on the proximal nail folds of the left hand digits two times per day for 30 days.
Saline solution drops placed on the proximal nail folds of the right hand digits two times per day for 30 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Nail Brittleness at 30 Days of Treatment</title>
          <description>Scale Title: Nail Brittleness (1-4)
Subjective assessment by subjects on scale of 1 (no brittleness) to 4 (maximum brittleness).</description>
          <population>No or incomplete data on seven subjects
Subjects were asked to assess nail brittleness of both hands and rank them together ‚Äì i.e. the value each subject gave for nail brittleness was the combination of the placebo hand and the treatment hand. Nail brittleness values were not distinguished between the placebo hands and the treatment hands.</population>
          <units>Score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.25" spread="0.93"/>
                    <measurement group_id="O2" value="2.43" spread="1.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison between baseline nail brittleness values and completion values</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.062</p_value>
            <p_value_desc>Threshold is p&lt;0.05</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Days Until the First Nail Chipped</title>
        <description>Average number of days post-treatment until the first nail chipped</description>
        <time_frame>Baseline to 30 days</time_frame>
        <population>- No nail chipping data on 12 participants</population>
        <group_list>
          <group group_id="O1">
            <title>Bimatoprost 0.01% Drops</title>
            <description>Bimatoprost 0.01%: Bimatoprost drops added to the proximal nail folds of the randomized study hand digits two times per day for 30 days</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Saline solution drops placed on the proximal nail folds of the hand digits opposite from the study hand two times per day for 30 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Days Until the First Nail Chipped</title>
          <description>Average number of days post-treatment until the first nail chipped</description>
          <population>- No nail chipping data on 12 participants</population>
          <units>Days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Hands</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Hands</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.38" spread="9.36"/>
                    <measurement group_id="O2" value="6.26" spread="8.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Skin Pigmentation on Hands</title>
        <description>Photographs taken (knuckle to fingertips over white paper with consistent bulb illumination at the site), with an Apple iPhone 6 (Cupertino, CA, USA) and examined. The investigators reviewed the anonymous photos by number to look for comparative skin pigmentation (increased pigmentation, decreased pigmentation, no change in pigmentation) changes on the hands.</description>
        <time_frame>Baseline, 30 days</time_frame>
        <population>Data omitted for 4 subjects with pigmented control and medication hands
No data for an additional 4 subjects due to poor photo quality</population>
        <group_list>
          <group group_id="O1">
            <title>Bimatoprost 0.01% Drops</title>
            <description>Bimatoprost 0.01%: Bimatoprost drops added to the proximal nail folds of the randomized study hand digits two times per day for 30 days</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Saline solution drops placed on the proximal nail folds of the hand digits opposite from the study hand two times per day for 30 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Skin Pigmentation on Hands</title>
          <description>Photographs taken (knuckle to fingertips over white paper with consistent bulb illumination at the site), with an Apple iPhone 6 (Cupertino, CA, USA) and examined. The investigators reviewed the anonymous photos by number to look for comparative skin pigmentation (increased pigmentation, decreased pigmentation, no change in pigmentation) changes on the hands.</description>
          <population>Data omitted for 4 subjects with pigmented control and medication hands
No data for an additional 4 subjects due to poor photo quality</population>
          <units>Hands</units>
          <param>Count of Units</param>
          <units_analyzed>Hands</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Hands</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Decreased Pigmentation</title>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No Change in Pigmentation</title>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="30"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Increased Pigmentation</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Hirsutism on Hands</title>
        <description>Photographs taken (knuckle to fingertips over white paper with consistent bulb illumination at the site), with an Apple iPhone 6 (Cupertino, CA, USA) and examined. The investigators reviewed the anonymous photos by number to look for comparative (increased hair growth, decreased hair growth, no change) hair changes on the hands.</description>
        <time_frame>Baseline, 30 days</time_frame>
        <population>- No data on 4 participants due to poor photo quality</population>
        <group_list>
          <group group_id="O1">
            <title>Bimatoprost 0.01% Drops</title>
            <description>Bimatoprost 0.01%: Bimatoprost drops added to the proximal nail folds of the randomized study hand digits two times per day for 30 days</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Saline solution drops placed on the proximal nail folds of the hand digits opposite from the study hand two times per day for 30 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Hirsutism on Hands</title>
          <description>Photographs taken (knuckle to fingertips over white paper with consistent bulb illumination at the site), with an Apple iPhone 6 (Cupertino, CA, USA) and examined. The investigators reviewed the anonymous photos by number to look for comparative (increased hair growth, decreased hair growth, no change) hair changes on the hands.</description>
          <population>- No data on 4 participants due to poor photo quality</population>
          <units>Hands</units>
          <param>Count of Units</param>
          <units_analyzed>Hands</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="34"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Hands</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Decreased Hair Growth</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No Change in Hair Growth</title>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                    <measurement group_id="O2" value="34"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Increased Hair Growth</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Bimatoprost 0.01% Drops</title>
          <description>Bimatoprost 0.01%: Bimatoprost drops added to the proximal nail folds of the randomized study hand digits two times per day for 30 days</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>Saline solution drops placed on the proximal nail folds of the hand digits opposite from the study hand two times per day for 30 days.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Nail chipping reduced the N value at the completion of the study. Suggestion is to etch the nail surface to create a mark, then measure from the nail fold to the nail etch at the end of the trial period.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. David J. Palmer</name_or_title>
      <organization>Department of Ophthalmology, Northwestern University Feinberg School of Medicine</organization>
      <phone>3126958150</phone>
      <email>dpalmermd@comcast.net</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

